These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 21216285)
21. Agglomeration of Ibuprofen with talc by novel crystallo-co-agglomeration technique. Pawar A; Paradkar A; Kadam S; Mahadik K AAPS PharmSciTech; 2004 Sep; 5(4):e55. PubMed ID: 15760052 [TBL] [Abstract][Full Text] [Related]
22. Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers. Kachrimanis K; Nikolakakis I; Malamataris S J Pharm Sci; 2000 Feb; 89(2):250-9. PubMed ID: 10688754 [TBL] [Abstract][Full Text] [Related]
23. Effect of a melt agglomeration process on agglomerates containing solid dispersions. Vilhelmsen T; Eliasen H; Schaefer T Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973 [TBL] [Abstract][Full Text] [Related]
24. Spheroidization of glass powders for glass ionomer cements. Gu YW; Yap AU; Cheang P; Kumar R Biomaterials; 2004 Aug; 25(18):4029-35. PubMed ID: 15046893 [TBL] [Abstract][Full Text] [Related]
25. Milling of agglomerates in an impact mill. Verheezen JJ; van der Voort Maarschalk K; Faassen F; Vromans H Int J Pharm; 2004 Jun; 278(1):165-72. PubMed ID: 15158958 [TBL] [Abstract][Full Text] [Related]
28. Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid. Manosroi A; Chutoprapat R; Abe M; Manosroi J Int J Pharm; 2008 Mar; 352(1-2):248-55. PubMed ID: 18036754 [TBL] [Abstract][Full Text] [Related]
29. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353 [TBL] [Abstract][Full Text] [Related]
30. Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery. Bakhbakhi Y; Charpentier PA; Rohani S Int J Pharm; 2006 Feb; 309(1-2):71-80. PubMed ID: 16412594 [TBL] [Abstract][Full Text] [Related]
31. Blending of agglomerates into powders 1: Quantification of abrasion rate. Willemsz TA; Oostra W; Hooijmaijers R; de Vegt O; Morad N; Vromans H; Frijlink HW; Van der Voort Maarschalk K Int J Pharm; 2010 Mar; 387(1-2):87-92. PubMed ID: 20015470 [TBL] [Abstract][Full Text] [Related]
32. Effect of particle properties on the flowability of ibuprofen powders. Liu LX; Marziano I; Bentham AC; Litster JD; White ET; Howes T Int J Pharm; 2008 Oct; 362(1-2):109-17. PubMed ID: 18652883 [TBL] [Abstract][Full Text] [Related]
33. Development of spherical iron(II) sulfate heptahydrate-containing solid particles with sustained drug release. Szabó-Révész P; Farkas B; Gregor T; Nagy K; Pallagi E Eur J Pharm Biopharm; 2007 May; 66(2):193-9. PubMed ID: 17125982 [TBL] [Abstract][Full Text] [Related]
34. Preparation and characteristics of microcapsules containing enoxacin by one continuous process of agglomeration and microencapsulation. Ueda M; Nakamura Y; Makita H; Kawashima Y J Microencapsul; 1993; 10(2):171-80. PubMed ID: 8331491 [TBL] [Abstract][Full Text] [Related]
35. Catalytic performance of nanosized Pt-Au alloy catalyst in oxidation of methanol and toluene. Kim KJ; Kim YH; Ahn HG J Nanosci Nanotechnol; 2007 Nov; 7(11):3795-9. PubMed ID: 18047061 [TBL] [Abstract][Full Text] [Related]
36. Following mechanical activation of salbutamol sulphate during ball-milling with isothermal calorimetry. Gaisford S; Dennison M; Tawfik M; Jones MD Int J Pharm; 2010 Jun; 393(1-2):74-8. PubMed ID: 20385222 [TBL] [Abstract][Full Text] [Related]
37. Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles. Raula J; Eerikäinen H; Kauppinen EI Int J Pharm; 2004 Oct; 284(1-2):13-21. PubMed ID: 15454292 [TBL] [Abstract][Full Text] [Related]
38. Spherical crystallization of celecoxib. Paradkar AR; Pawar AP; Chordiya JK; Patil VB; Ketkar AR Drug Dev Ind Pharm; 2002 Nov; 28(10):1213-20. PubMed ID: 12476867 [TBL] [Abstract][Full Text] [Related]
39. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization. Murnane D; Marriott C; Martin GP Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385 [TBL] [Abstract][Full Text] [Related]
40. Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method. Sano A; Kuriki T; Kawashima Y; Takeuchi H; Hino T; Niwa T Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):733-9. PubMed ID: 2347016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]